IDXX:NASDAQ
IDEXX Laboratories Inc
517,75 USD
arrow_downward
-0,85%(-4,44) 1d
517,75 USD
0,00% (0,00)
bedtimeFora d'horari
Tancat: 1 d’oct., 16:00:01 GMT-4 · USD
search
Tots els símbols
| Símbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadístiques principals per a IDXX...
Obre
521,58 USD
Alt
525,96 USD
Baix
517,06 USD
Capitalització borsària
40,79 kM
Volum mitjà
491,20 k
Volum
319,34 k
Ràtio preu-benefici
36,39
Alt 52 setmanes
769,98 USD
Baix 52 setmanes
500,61 USD
BPA
14,23 USD
Versió beta
1,54
Accions en circulació
78,78 M
Nombre d'empleats
11 k
Obre
521,58 USD
Alt
525,96 USD
Baix
517,06 USD
Capitalització borsària
40,79 kM
Volum mitjà
491,20 k
Volum
319,34 k
Ràtio preu-benefici
36,39
Alt 52 setmanes
769,98 USD
Baix 52 setmanes
500,61 USD
BPA
14,23 USD
Versió beta
1,54
Accions en circulació
78,78 M
Nombre d'empleats
11 k
Notícies
De fonts web i partners de notícies
Yahoo Finance UK
·
fa 6 hores
IDEXX Laboratories to Release 2026 Third Quarter Financial Results
Yahoo Finance
·
fa 17 hores
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts
News Corp
·
fa 1 dia
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors
Stock Titan
·
fa 1 dia
An AI tool that helps veterinarians document care is now owned by IDEXX.
Perfil
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.
In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
Sobre IDEXX Laboratories Inc
Conseller delegatJay Mazelsky
Empleats11 k
Fundació19 de des. 1983
Seu principalWestbrook, Maine, Estats Units d'Amèrica
Sector-
Lloc webidexx.com